Immunocytodiagnosis of atypical hyperplasia and endometrial carcinoma in post-menopausal women
- 30 July 1992
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 51 (6) , 869-872
- https://doi.org/10.1002/ijc.2910510606
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Value of immunohistochemical demonstration of several epithelial markers in hyperplastic and neoplastic endometriumGynecologic Oncology, 1990
- Combinations of monoclonal antibodies can distinguish primary lung tumors from metastatic lung tumors sampled by fine needle aspiration biopsyCancer, 1989
- Patterns of reactivity with the monoclonal antibodies HMFG1 and HMFG2 in normal endometrium, endometrial hyperplasia and adenocarcinomaHistopathology, 1989
- The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasiaAmerican Journal of Obstetrics and Gynecology, 1989
- Endometrial cytology: Six years of experienceDiagnostic Cytopathology, 1987
- The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patientsCancer, 1985
- Nuclear size and shape of epithelial cells from the endometrium: lack of value as a criterion for differentiation between normal, hyperplastic, and malignant conditions.Journal of Clinical Pathology, 1985
- Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinomaCancer, 1982
- Endometrial Carcinoma and 11s Precursors: Detection and ScreeningClinical Obstetrics and Gynecology, 1982
- Inadequacy of Papanicolaou Smears in the Detection of Endometrial CancerNew England Journal of Medicine, 1974